Desloratadine
This medicine should always be taken exactly as described in this patient leaflet or as directed by a doctor or pharmacist.
Dynid Gem contains desloratadine, which is an antihistamine.
Dynid Gem is an anti-allergic medicine that does not cause drowsiness. It helps control allergic reactions and their symptoms.
Relief from these symptoms lasts throughout the day, making it easier to return to normal daily activities and normal sleep.
If there is no improvement or the patient feels worse, they should consult their doctor.
Before taking Dynid Gem, the patient should discuss it with their doctor, pharmacist, or nurse:
This medicine should not be given to children under 12 years of age.
No interactions with other medicines are known.
The patient should inform their doctor or pharmacist about all medicines they are taking, have recently taken, or plan to take.
Dynid Gem, 5 mg, tablets can be taken with or without food.
Care should be taken when taking Dynid Gem with alcohol.
If the patient is pregnant, breastfeeding, or thinks they may be pregnant, they should consult their doctor or pharmacist before taking this medicine.
Dynid Gem should not be taken during pregnancy or breastfeeding.
There are no available data on the effect on fertility in men and women.
It is unlikely that this medicine will affect the ability to drive or use machines. Although most people do not experience drowsiness, it is recommended to avoid activities that require concentration, such as driving or using machines, until it is known how the medicine affects them.
If the patient has previously been diagnosed with intolerance to some sugars, they should consult their doctor before taking the medicine.
This medicine should always be taken exactly as described in the patient leaflet or as directed by a doctor or pharmacist. If in doubt, the patient should consult their doctor or pharmacist.
The recommended dose is one tablet once a day, taken with water, with or without food.
This medicine is for oral use.
The tablet should be swallowed whole.
The doctor will determine the duration of treatment with Dynid Gem based on the type of allergic rhinitis the patient has.
If the patient has seasonal allergic rhinitis (symptoms that occur for less than 4 days a week or for less than 4 weeks), the doctor will recommend a treatment schedule based on the patient's medical history.
If the patient has chronic allergic rhinitis (symptoms that occur for at least 4 days a week and for more than 4 weeks), the doctor may recommend longer use of the medicine.
In urticaria, the duration of treatment may vary from patient to patient, and the patient should follow the doctor's recommendations.
Dynid Gem should be taken as recommended in the leaflet. If the patient accidentally takes more than the recommended dose, they should inform their doctor, pharmacist, or nurse immediately.
If a dose is missed, it should be taken as soon as possible, and then the patient should return to their regular dosing schedule.
A double dose should not be taken to make up for a missed dose.
If the patient has any further questions about taking this medicine, they should consult their doctor, pharmacist, or nurse.
Like all medicines, Dynid Gem can cause side effects, although not everybody gets them.
After desloratadine was introduced, very rare but serious allergic reactions (difficulty breathing, wheezing, itching, hives, and swelling of the face, tongue, or throat) have been reported. If any of these serious side effects occur, the patient should stop taking the medicine and see a doctor immediately.
In clinical studies, side effects in adults were almost the same as with a placebo. However, fatigue, dry mouth, and headache were reported more often than with a placebo. In adolescents, the most commonly reported side effect was headache.
The following side effects have been reported in clinical studies of desloratadine:
Common:may affect up to 1 in 10 people
After desloratadine was introduced, the following side effects have been reported:
Very rare:may affect up to 1 in 10,000 people
Frequency not known:frequency cannot be estimated from the available data
Children
Frequency not known:frequency cannot be estimated from the available data.
If the patient experiences any side effects, including any side effects not listed in the leaflet, they should inform their doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help gather more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Do not take this medicine after the expiry date stated on the carton after "EXP" and on the blister after "EXP".
The expiry date refers to the last day of the month.
There are no special storage instructions for this medicine.
Do not take this medicine if the patient notices any change in the appearance of the tablet.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines they no longer use. This will help protect the environment.
Dynid Gem is a almost white to light pink, round, biconvex tablet with "L5" engraved on one side and smooth on the other.
Dynid Gem is available in blisters of 10 tablets in a cardboard box.
Glenmark Pharmaceuticals s.r.o.
Hvĕzdova 1716/2b
140 78 Prague 4
Czech Republic
Glenmark Pharmaceuticals s.r.o.
Fibichova 143
566 17 Vysoké Mýto
Czech Republic
Glenmark Pharmaceuticals Sp. z o. o.
ul. Dziekońskiego 3
00-728 Warsaw
Email: poland.receptionist@glenmarkpharma.com
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.